# Mesenchymal Stem Cells for Age-Related Frailty

> **NCT05284604** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **VA Office of Research and Development**

## Conditions studied

- Frailty

## Interventions

- **DRUG:** Mesenchymal Stem Cells (MSCs)

## Key facts

- **NCT ID:** NCT05284604
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-31
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2023-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05284604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05284604, "Mesenchymal Stem Cells for Age-Related Frailty". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05284604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*